German Biotech BioNTech Locks in $270M Series A Post author:Sam Post published:January 3, 2018 Post category:BioPharma The Company previously completed a seed round fundraising in 2008 concurrent with its founding. Source: BioSpace You Might Also Like How Gilead Just Lost $9 Billion in Market Value This Week February 8, 2017 Why This SoCal Pharma Could Be Your Best Bet on Alzheimer's April 24, 2017 Amphastar Reports Financial Results For The Three Months And Fiscal Year Ended December 31, 2016 March 13, 2017
Amphastar Reports Financial Results For The Three Months And Fiscal Year Ended December 31, 2016 March 13, 2017